Lanzamiento Enero 2027

Metaanálisis2015

Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis

Smoot B, Chiavola-Larson L, Lee J, Manibusan H, Allen DD

Journal of cancer survivorship : research and practice · 70 citas

Cómo se estudió

Diseño
Metaanálisis (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Center for Advancing Translational Sciences
Gobierno
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Gobierno
NCATS NIH HHS
Gobierno
NICHD NIH HHS
Subvenciones
National Center for Advancing Translational Sciences (KL2-TR-000143); Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD052163)

Según 4 financiadores declarados.

Publicación

Publicado
2014-11-29 · J Cancer Surviv · vol. 9 · número 2 · págs. 287–304
Editorial
Springer Science+Business Media
Citado
112 citas · más que el 68% de estudios similares · 1.0× el promedio de su campo
Referencias
36 trabajos
Acceso
De pago
Áreas de investigación
Laser Applications in Dentistry and Medicine · Lymphatic System and Diseases · Dermatologic Treatments and Research
Palabras clave
low-level laser therapy, breast cancer-related lymphedema, arm lymphedema, limb volume reduction, analgesia, swelling, breast cancer survivors
MeSH
humans, breast neoplasms, pain, lymphedema, treatment outcome, mastectomy, adult, survivors, female, pain management, low-level light therapy

5 autores

  • Betty J. Smoot🇺🇸 · autor de correspondenciaUniversity of California, San Francisco; San Francisco State University
  • Laura Chiavola-Larson🇺🇸Dominican Hospital
  • Jeannette Y. Lee🇺🇸University of California, San Francisco; San Francisco State University
  • Hidelisa Manibusan🇺🇸University of California, San Francisco
  • Diane D. Allen🇺🇸University of California, San Francisco; San Francisco State University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Purpose

This study aims to examine literature on effectiveness of low-level laser therapy (LLLT) in reducing limb volume and pain in adults with breast cancer-related lymphedema (BCRL).

Methods

PubMed, PEDro, CINAHL, and Cochrane databases were searched using (lymphedema OR edema OR swelling) AND (breast cancer OR mastectomy) AND (laser OR low-level laser therapy OR LLLT OR cold laser). Intervention studies or meta-analyses reporting LLLT for BCRL were included in the search. Pooled effect sizes (ES) and 95 % confidence intervals (CI) were calculated for volume and pain. No limitations were placed on length of follow-up, publication year, or language. Final search was conducted on October 16, 2014.

Results

Nine studies met criteria for inclusion. Within-group pooled ES for volume (six studies) was -0.52 (-0.78, -0.25), representing a 75.7-ml reduction in limb volume after LLLT. Between-group pooled ES for volume (four studies) was -0.62 (-0.97, -0.28), representing a 90.9-ml greater reduction in volume with treatment including LLLT versus not including LLLT. Within-group pooled ES for pain reduction (three studies) was -0.62 (-1.06, -0.19), pain reduction of 13.5 mm (0-100 mm VAS). Between-group pooled ES for pain reduction (two studies) was non-significant at -1.21 (-4.51, 2.10).

Conclusion

Moderate-strength evidence supports LLLT in the management of BCRL, with clinically relevant within-group reductions in volume and pain immediately after conclusion of LLLT treatments. Greater reductions in volume were found with the use of LLLT than in treatments without it.

Implications for cancer survivors

LLLT confers clinically meaningful reductions in arm volume and pain in women with BCRL.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.